UMH Properties Inc
Change company Symbol lookup
Select an option...
UMH UMH Properties Inc
NRDY Nerdy Inc
FSK FS KKR Capital Corp
FSPHX Fidelity® Select Health Care Portfolio
UZAPF Flughafen Zuerich AG
SLVO Credit Suisse X-Links Silver Shares Covered Call ETN
ARQQ Arqit Quantum Inc
MA Mastercard Inc
BEN Franklin Resources Inc
REGN Regeneron Pharmaceuticals Inc
Go

Real Estate : Equity Real Estate Investment Trusts (REITs) | Small Cap Blend
Company profile

UMH Properties, Inc. (UMH) is a real estate investment trust (REIT). The Company's primary business is the ownership and operation of manufactured home communities, including leasing manufactured home sites to private manufactured home owners. The Company also leases homes to residents, and through its taxable REIT subsidiary, UMH Sales and Finance, Inc. (S&F), conducts manufactured home sales in its communities. The Company owns around 126 manufactured home communities consisting of approximately 23,700 developed homesites. The communities are located in New Jersey, New York, Ohio, Pennsylvania, Tennessee, Indiana, Maryland, Michigan, Alabama and South Carolina. In connection with the operation of its communities, UMH also leases homes to prospective tenants. These rental homes are owned by the Company and rented to residents.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$23.90
Day's Change
-0.57 (-2.33%)
Bid
--
Ask
--
B/A Size
--
Day's High
24.72
Day's Low
23.89
Volume
(Average)
Volume:
272,517

10-day average volume:
293,565
272,517

Teladoc stock drops after telemedicine company reports wider quarterly loss

4:56 pm ET July 27, 2021 (MarketWatch)
Print

Teladoc Health Inc. (TDOC) shares fell more than 7% in the extended session Tuesday after the telemedicine company reported a wider-than-expected second-quarter loss and guided for a wider per-share loss for the year than analysts forecast. Teladoc said it lost $133.8 million, or 86 cents a share, in the second quarter, compared with a loss of $25.7 million, or 34 cents a share, in the year-ago period. Revenue rose to $503 million from $241 million a year ago. Analysts polled by FactSet had expected a loss of 53 cents a share on sales of $501 million in the quarter. The company said that its telehealth visits topped 3.5 million, 28% higher than the second quarter of 2020, in the first wave of the pandemic. Teladoc also guided for third-quarter revenue between $510 million and $520 million, and a net loss between 78 cents a share and 68 cents a share. For the full year, the company guided for revenue between $2 billion and $2.025 billion, alongside a per-share loss between $3.60 and $3.35. The analysts surveyed by FactSet expect a loss of $2.84 a share for the year. Teladoc shares ended the regular trading day up 0.8%.

-Claudia Assis; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

July 27, 2021 16:56 ET (20:56 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.